Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
Publication
, Journal Article
McKenney, JM; Davidson, MH; Jacobson, TA; Guyton, JR; National Lipid Association Statin Safety Assessment Task Force
Published in: Am J Cardiol
April 17, 2006
This article summarizes the final conclusions of the National Lipid Association (NLA) Statin Safety Task Force, based on a review and independent research of New Drug Application (NDA) information, US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) data, cohort and clinical trial results, and analysis of administrative claims database information and the assessment of its 4 Expert Panels, which focused on issues of statin safety with regard to liver, muscle, renal, and neurologic systems. Practical guidance in the form of recommendations to health professionals who manage the coronary artery disease risk of patients with statin therapy is provided.
Duke Scholars
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
April 17, 2006
Volume
97
Issue
8A
Start / End Page
89C / 94C
Location
United States
Related Subject Headings
- Renal Insufficiency
- Proteinuria
- Peripheral Nervous System Diseases
- Muscular Diseases
- Liver Failure
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Dose-Response Relationship, Drug
- Dementia
- Databases, Factual
Citation
APA
Chicago
ICMJE
MLA
NLM
McKenney, J. M., Davidson, M. H., Jacobson, T. A., Guyton, J. R., & National Lipid Association Statin Safety Assessment Task Force, . (2006). Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol, 97(8A), 89C-94C. https://doi.org/10.1016/j.amjcard.2006.02.030
McKenney, James M., Michael H. Davidson, Terry A. Jacobson, John R. Guyton, and John R. National Lipid Association Statin Safety Assessment Task Force. “Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.” Am J Cardiol 97, no. 8A (April 17, 2006): 89C-94C. https://doi.org/10.1016/j.amjcard.2006.02.030.
McKenney JM, Davidson MH, Jacobson TA, Guyton JR, National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006 Apr 17;97(8A):89C-94C.
McKenney, James M., et al. “Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.” Am J Cardiol, vol. 97, no. 8A, Apr. 2006, pp. 89C-94C. Pubmed, doi:10.1016/j.amjcard.2006.02.030.
McKenney JM, Davidson MH, Jacobson TA, Guyton JR, National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006 Apr 17;97(8A):89C-94C.
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
April 17, 2006
Volume
97
Issue
8A
Start / End Page
89C / 94C
Location
United States
Related Subject Headings
- Renal Insufficiency
- Proteinuria
- Peripheral Nervous System Diseases
- Muscular Diseases
- Liver Failure
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Dose-Response Relationship, Drug
- Dementia
- Databases, Factual